HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty.

Abstract
Hypertension is a well-known risk factor for atherosclerosis. However, data on the impact of hypertension in patients with ST elevation myocardial infarction (STEMI) are inconsistent and mainly related to studies performed in the thrombolytic era, with very few data on patients undergoing primary angioplasty. The aim of the present study was to evaluate the impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with STEMI undergoing primary percutaneous coronary intervention. Our population is represented by 1,662 patients undergoing primary angioplasty for STEMI included in the Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty database. Myocardial perfusion was evaluated by myocardial blush grade and ST segment resolution. Follow-up data were collected within 1 year after primary angioplasty. Hypertension was observed in 700 patients (42.1%). Hypertension was associated with more advanced age (p <0.001), female gender (p <0.001), diabetes (p <0.001), hypercholesterolemia (p <0.001), previous revascularization (p <0.001), anterior myocardial infarction (p = 0.006), longer ischemia time (p = 0.03), more extensive coronary artery disease (p = 0.002), more often treated with abciximab (p <0.001), and less often smokers (p <0.001). Hypertension was associated with impaired postprocedural myocardial blush grade 2 to 3 (68.2% vs 74.2%, p = 0.019) and complete ST segment resolution (51.7% vs 61.1%, p = 0.001). By a mean follow-up of 206 ± 158 days, 70 patients (4.3%) had died. Hypertension was associated with a greater mortality (6.2% vs 2.9%, hazard ratio 2.31, 95% confidence interval 1.42 to 3.73, p <0.001), confirmed after correction for baseline confounding factors (hazard ratio 1.82, 95% confidence interval 1.03 to 3.22, p <0.001). In conclusion, this study showed that among patients with STEMI undergoing primary angioplasty, hypertension is associated with impaired reperfusion and independently predicts 1-year mortality.
AuthorsGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, C Michael Gibson, Francesco Bellandi, Hans-Richard Arntz, Mauro Maioli, Marko Noc, Simona Zorman, Uwe Zeymer, H Mesquita Gabriel, Ayse Emre, Donald Cutlip, Tomasz Rakowski, Maryann Gyongyosi, Dariusz Dudek, EGYPT cooperation
JournalThe American journal of cardiology (Am J Cardiol) Vol. 112 Issue 8 Pg. 1083-6 (Oct 15 2013) ISSN: 1879-1913 [Electronic] United States
PMID23910428 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Topics
  • Angioplasty, Balloon, Coronary
  • Coronary Circulation (physiology)
  • Electrocardiography
  • Embolism (epidemiology, etiology)
  • Female
  • Follow-Up Studies
  • Global Health
  • Humans
  • Hypertension (complications, mortality, physiopathology)
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction (mortality, physiopathology, surgery)
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate (trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: